| 摘要 |
Based on the unexpected association of a SOAT1 gene polymorphism with reduced genetic risk for a neurodegenerative disease, in particular Alzheimer's disease, the present invention provides a method of diagnosing or prognosticating such a disease, or determining the propensity or predisposition of a subject to develop such a disease. The method comprises detecting the presence or absence of a single nucleotide polymorphism in the SOAT1 gene which encodes the enzmye ACAT1, acyl-coenzyme A: cholesterol acyltransferase 1. |
